{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:53:06Z","timestamp":1790679186795,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":3508,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1038\/sj.mt.6300066","type":"journal-article","created":{"date-parts":[[2006,12,26]],"date-time":"2006-12-26T15:04:48Z","timestamp":1167145488000},"page":"492-500","source":"Crossref","is-referenced-by-count":82,"title":["Correction of the Biochemical and Functional Deficits in Fabry Mice Following AAV8\u2013mediated Hepatic Expression of \u03b1-galactosidase A"],"prefix":"10.1016","volume":"15","author":[{"given":"Robin J","family":"Ziegler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribeth","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M","family":"Barbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chester","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Bercury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Armentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng H","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/sj.mt.6300066_bib1","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1001\/jama.284.21.2771","article-title":"Clinical features of and recent advances in therapy","volume":"284","author":"Brady","year":"2000","journal-title":"JAMA"},{"key":"10.1038\/sj.mt.6300066_bib2","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3733","article-title":"\u03b1-Galactosidase A deficiency: Fabry disease","author":"Desnick","year":"2001"},{"key":"10.1038\/sj.mt.6300066_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-138-4-200302180-00014","article-title":"Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy","volume":"138","author":"Desnick","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1038\/sj.mt.6300066_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase A-replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.mt.6300066_bib5","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease. A randomized controlled trial","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1038\/sj.mt.6300066_bib6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of \u03b1-galactosidase A replacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1038\/sj.mt.6300066_bib7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/glycob\/cwg034","article-title":"A biochemical and pharmacological comparison of enzyme replacement therapies for the glycolipid storage disorder Fabry disease","volume":"13","author":"Lee","year":"2003","journal-title":"Glycobiology"},{"key":"10.1038\/sj.mt.6300066_bib8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1006\/mthe.2002.0605","article-title":"Adenovirus-transduced lung as a portal for delivering \u03b1-galactosidase A into systemic circulation for Fabry disease","volume":"5","author":"Li","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300066_bib9","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.222221899","article-title":"Long-term systemic therapy of Fabry disease in a knock-out mouse by adeno-associated virus-mediated muscle-directed gene transfer","volume":"99","author":"Takahashi","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300066_bib10","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/sj.gt.3302092","article-title":"Gene therapy progress and prospects: gene therapy of lysosomal storage disorders","volume":"10","author":"Cheng","year":"2003","journal-title":"Gene Ther"},{"key":"10.1038\/sj.mt.6300066_bib11","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1073\/pnas.0537900100","article-title":"Long-term correction of globotriaosylceramide storage in Fabry mice by recombinant adeno-associated virus-mediated gene transfer","volume":"100","author":"Park","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300066_bib12","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ymthe.2003.11.015","article-title":"AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of \u03b1-galactosidase A and the induction of immune tolerance in Fabry mice","volume":"9","author":"Ziegler","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300066_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/jgm.468","article-title":"Partial correction of the \u03b1-galactosidase A deficiency and reduction of glycolipid storage in Fabry mice using synthetic vectors","volume":"6","author":"Przybylska","year":"2004","journal-title":"J Gene Med"},{"key":"10.1038\/sj.mt.6300066_bib14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.ASN.0000043901.45141.D4","article-title":"Fabry disease is associated with age-dependent susceptibility to vascular thrombosis","volume":"14","author":"Eitzman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.mt.6300066_bib15","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/mus.10236","article-title":"Physiologic characterization of neuropathy in Fabry disease","volume":"26","author":"Luciano","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1038\/sj.mt.6300066_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.2002.tb03108.x","article-title":"Evaluation of peripheral and autonomic nerve function in Fabry disease","volume":"439","author":"Hilz","year":"2002","journal-title":"Acta Paediatr Suppl"},{"key":"10.1038\/sj.mt.6300066_bib17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1212\/01.WNL.0000118207.84514.40","article-title":"Enzyme replacement therapy improves function of C-, A\u03b4-, and A\u03b2-nerve fibers in Fabry neuropathy","volume":"62","author":"Hilz","year":"2004","journal-title":"Neurology"},{"key":"10.1038\/sj.mt.6300066_bib18","doi-asserted-by":"crossref","first-page":"11854","DOI":"10.1073\/pnas.182412299","article-title":"Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy","volume":"99","author":"Gao","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300066_bib19","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1182\/blood-2004-10-3867","article-title":"Sustained correction of disease in na\u00efve and AAV2-pretreated hemophilia B dogs: AAV2\/8-mediated, liver-directed gene therapy","volume":"105","author":"Wang","year":"2005","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300066_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ymthe.2005.03.011","article-title":"AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann\u2013Pick disease","volume":"12","author":"Barbon","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300066_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ymthe.2004.10.004","article-title":"Efficacy of an adeno-associated virus 8-pseudotyped vector in glycogen storage disease type II","volume":"11","author":"Sun","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300066_bib22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jgm.901","article-title":"AAV8-mediated expression of glucocerebrosidase ameliorates the storage pathology in the visceral organs of a mouse model of Gaucher disease","volume":"8","author":"McEachern","year":"2006","journal-title":"J Gene Med"},{"key":"10.1038\/sj.mt.6300066_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/00004691-200212000-00011","article-title":"Small fiber dysfunction predominates in Fabry neuropathy","volume":"19","author":"Dutsch","year":"2002","journal-title":"J Clin Neurophysiol"},{"key":"10.1038\/sj.mt.6300066_bib24","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1089\/10430349950017671","article-title":"Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer","volume":"10","author":"Ziegler","year":"1999","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300066_bib25","doi-asserted-by":"crossref","first-page":"7515","DOI":"10.1073\/pnas.120177997","article-title":"Long-term enzyme correction and lipid reduction in multiple organs or primary and secondary transplanted Fabry mice receiving transduced bone marrow cells","volume":"97","author":"Takenaka","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300066_bib26","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1073\/pnas.051634498","article-title":"Adeno-associated viral vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs of Fabry mice","volume":"98","author":"Jung","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.mt.6300066_bib27","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/01.ATV.0000231520.26490.54","article-title":"Complete prevention of atherosclerosis in apoE-deficient mice by hepatic human apoE gene transfer with adeno-associated virus serotypes 7 and 8","volume":"26","author":"Kitajima","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1038\/sj.mt.6300066_bib28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.ymthe.2004.12.022","article-title":"Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models","volume":"11","author":"Davidoff","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300066_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ymthe.2005.08.017","article-title":"Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primates","volume":"13","author":"Gao","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300066_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/hum.2006.17.427","article-title":"Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia A dogs and mice","volume":"17","author":"Sarkar","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1038\/sj.mt.6300066_bib31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","article-title":"Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis","volume":"8","author":"McCarty","year":"2001","journal-title":"Gene Ther"},{"key":"10.1038\/sj.mt.6300066_bib32","doi-asserted-by":"crossref","first-page":"6192","DOI":"10.1128\/JVI.00526-06","article-title":"High-level transgene expression in nonhuman primate liver with novel adeno-associated virus serotypes containing self-complementary genomes","volume":"80","author":"Gao","year":"2006","journal-title":"J Virol"},{"key":"10.1038\/sj.mt.6300066_bib33","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1182\/blood-2005-10-4035","article-title":"Self-complementary adeno-associated virus vectors containing a novel liver-specific human factor IX expression cassette enable highly efficient transduction of murine and nonhuman primate liver","volume":"107","author":"Nathwani","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300066_bib34","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/WNL.52.6.1249","article-title":"Quantitative analysis of epidermal innervation in Fabry disease","volume":"52","author":"Scott","year":"1999","journal-title":"Neurology"},{"key":"10.1038\/sj.mt.6300066_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/mus.20550","article-title":"Enzyme replacement therapy and intraepidermal innervation density in Fabry disease","volume":"34","author":"Schiffmann","year":"2006","journal-title":"Muscle Nerve"},{"key":"10.1038\/sj.mt.6300066_bib36","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1182\/blood-2004-03-0847","article-title":"Induction of antigen-specific CD4+ T-cell anergy and deletion by in vivo viral gene transfer","volume":"104","author":"Dobrzynski","year":"2004","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300066_bib37","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ymthe.2005.04.024","article-title":"Evasion of immune responses to introduced human acid alpha-glucosidase by liver-restricted expression in glycogen storage disease type II","volume":"12","author":"Franco","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300066_bib38","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI200316887","article-title":"Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer","volume":"111","author":"Mingozzi","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.mt.6300066_bib39","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2006-04-017913","article-title":"Effects of transient immunosuppression on adeno associated virus-mediated, liver-directed gene transfer in rhesus macaques and implications for human gene therapy","volume":"108","author":"Jiang","year":"2006","journal-title":"Blood"},{"key":"10.1038\/sj.mt.6300066_bib40","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ymthe.2005.06.475","article-title":"Local delivery of a viral vector mitigates neutralization by antiviral antibodies and results in efficient transduction of rabbit liver","volume":"12","author":"Hodges","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/sj.mt.6300066_bib41","first-page":"385","article-title":"Synthetic analgesics. II. Dithienylbutenylamines and dithienylbutylamines","volume":"107","author":"Eddy","year":"1953","journal-title":"J Pharm Exp Ther"},{"key":"10.1038\/sj.mt.6300066_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/abio.1998.2966","article-title":"Quantitative determination of globotriasoylceramide by immunodetection of glycolipid-bound recombinant verotoxin B subunit","volume":"267","author":"Zeidner","year":"1999","journal-title":"Anal Biochem"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616313089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616313089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T13:52:36Z","timestamp":1547128356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616313089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1525001616313089"],"URL":"https:\/\/doi.org\/10.1038\/sj.mt.6300066","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}